statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Instil Bio Non-GAAP EPS of -$1.26 beats by $2.14...

Instil Bio Non-GAAP EPS of -$1.26 beats by $2.14

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
TIL stock results show that Instil Bio beat analyst estimates for earnings per share the fourth quarter of 2023.
The post TIL Stock...

TIL Stock Earnings: Instil Bio Beats EPS for Q4 2023

DALLAS, March 21, 2024 (GLOBE NEWSWIRE) -- Instil Bio, Inc. ( Instil ) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today reported...

Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

DALLAS, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Instil Bio, Inc. ( Instil or the Company ) (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte...

Instil Bio Announces Strategic Update

Instil Bio, Inc. is a clinical-stage biopharmaceutical company engaged in developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte therapies for the treatment of patients with cancer. The company was founded in August 2018 and is headquartered in Dallas, TX.

Instil Bio Inc

Volume	2,143.00
52-Wk High	$14.00
52-Wk Low	$6.07

TIL Instil Bio Inc

About

Feed

News

Sentiment

Earnings

Fundamentals